CDKN2A and astrocytoma (excluding glioblastoma): We have previously identified a family with a history of early-onset melanoma and astrocytoma with an allelic loss of function of CDKN2A p14ARF-specific transcript mutation (c.193G>A; p.G65S) and the ATM Ser49Cys allele [15].